Farmacologie
BIBLIOGRAFIE SELECTIVĂ
1.ALLAIN P. – Pharmacologie – Les medicaments, Editions ESTEM, Paris, 1996
2.BARAN D. – Dimensiunea cronobiologică în medicină, Ed Apollonia Iaşi, 1998.
3.BARASH P.G., CULLEN B.F., STOELTING R.K. – Clinical anesthesia, third edition, Lippincot Raven Publishers, 385-440, 1998.
4.BOWMAN W.C. – Pharmacology of neuromuscular function, John Wright and Sons, Bristol, 66-70, 1980.
5.COMAN OANA ANDREEA – Interactiuni medicamentoase, Ed. Medicala, Bucuresti, 1998.
6.CRISTEA A.N. – Farmacologie generală, Ed. Did. Ped., Bucureşti, 1998.
7.CUPARENCU B, FIMAR M – Receptorii farmacologici, Gloria Publishing House, Cluj Napoca, 1998.
8.CUPARENCU B, PLEŞCA L. – Actualităţi în farmacologie şi fiziopatologie, Ed. Dacia, Cluj Napoca, 1995.
9.DOBRESCU D. - Farmacoterapie, Ed. Medicală, Bucureşti, 1981.
10.DOBRESCU D. - Gerontofarmacologie, Ed. Mondan, Bucureşti, 1995.
11.DOGARU T.M., FESZT G., VARI C.E., MĂRUŞTERI M. - Farmacologie experimentală, UMF Tg. Mureş, 1998.
12.DUVALESTIN P – Pharmacologie en practique anesthesique, 7-eme edition revue et augmentee, Masson, Paris, 100-129, 1989.
13.FARLOW C.A. – Pharmacogenomics,Ann NY Acad Sci, 802:101 –110, 1996. 14.GAVRILESCU C.M., MUNGIU O.C. – Farmacoepidemiologie, Ed. Polirom, Iaşi, 2002. 15.GUYTON, A.C. - Textbook of Medical Physiology, W.B.Saunders, Philadelphia, 67-95,1991. 16.HARDMAN G.J., LIMBIRD E.L., GOODMAN GILMAN A. – Goodman & Gilman's - The
pharmacological basis of therapeutics - 10th ed., McGraw-Hill, New York, 2001. 17.HĂULICĂ.I. – Fiziologia umană, Ediţia aII-a, Ed. Med. Bucureşti, 1996.
18.HRISCU ANISOARA, PAVELESCU M. – Farmacologia sistemului nervos, UMF Iasi, 1998. 19.KALOW W. – Pharmacogenetics in biological perspective, Pharmacological Reviews, 49,4:
369-380, 1997.
20.KATZ D.A. – Associating genes to drug response, Drug Information Journal, 36:751-761, 2002.
21.KATZUNG B.G. – Basic and clinical pharmacology, 7th edition, Appelton and Lange, Stanford,
Farmacologie
1998.
22.KUIVENHOVEN A.S. – Parvastatin response in aterosclerotic patients in function of their CETP phenotype, N Engl J Med, 338: 86-89, 1998.
23.LEUCUŢA S.E. – Biofarmacie şi farmacocinetică, Ed. Dacia, Cluj Napoca, 2002.
24.LEVY A.R. – Ethnic and racial differences in response to medicines, National pharmaceutical council,1993.
25.LUPUŞORU C.E. – Farmacologie, ed. Moldova, Iaşi, 1994.
26.MEYER U.A. – Pharmacogenetics and adverse drug reactions, Lancet, 356 (9242):1667-71, 2000.
27.MIHALAŞ G.I. – Utilizarea computerului în farmacologie. Informatica Medicală (Popescu O. coordonator), Ed. Medicală, Bucureşti, 1988.
28.MUNGIU O. C. (sub redacţia) – Tratat de algeziologie. Ed. Polirom, Iaşi, 2002.
29.MUNGIU O.C. – Elemente de farmacologie si testare a medicamentului, UMF Iasi « Gr. T. Popa », 1995.
30.MUNGIU O.C. – Elemente de farmacologie fundamentală, UMF « Gr. T. Popa » Iasi, 1995. 31.MUNGIU O.C. – Farmacologie medicală – curs, UMF« Gr. T. Popa », Iaşi, 1977. 32.MUNGIU O.C., PAVELIU F., PAVELIU S. – Farmacologie biochimică, Ed. Infomedica,
Bucureşti, 2000.
33.MYCEK M.J., HARVEY R. A., CHAMPE P. C., FISHER B.C. - Lippincott’s Illustrated ReviewsPharmacology, 2nd edition, Lippincott Williams and Wilkins, Maryland, USA, 1997.
34.OLCKERS A., MEYERS D.A., MEYERS S. – Adult muscle sodium channel alpha-subunit is a gene candidate for malignant hypertermia susceptibility. Genomics, 14: 829, 1992
35.OTSU, K., NISHIDA, K., KIMURA, Y., KUZUYA, T., HORI, M., KAMADA, T., TADA, M. - The
point mutation Arg615-Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. J. Biol. Chem, 269:9413-9415., 1994.
36.PATRAŞ X., MUNGIU O.C. – Miorelaxantele, Ed. Sedcom Libris, Iaşi, 2003.
37.PATRAŞ XENIA – Studiul experimental al acţiunii miorelaxantelor asupra hipertoniilor, Teză de doctorat, UMF « gr. T. Popa » Iaşi, 2002.
38.PATRAŞ X., TUDOSE C. – Farmacogenetica, Ed. Tehnopress Iaşi, 2003.
39.ROCSIN M.A., PLAUCHITHIU D.M., LAZĂR E. – Farmacodinamie experimentală practică, Ed. « V. Goldiş », Arad, 1997.
40.RUANO-RAVINA A., FIGUEIRAS A, BARROS-DIOS J.M. – The genomics revolution: will this
Farmacologie
mean a resurgence of customized prescriptions? Drug information Journal, 36: 725-726, 2002.
41.SIMIONOVICI M., CÂRSTEA A., VLĂDRESCU c. – cercetarea farmacologică şi prospectarea medicamentelor, Ed. Medicală, Bucureşti, 1983
42.SMITH C.M., REYNARD A.M. – Textbook of Pharmacology, W.B. Saunders, 1992. 43.STROESCU V. – Bazele farmacologice ale practicii medicale, Ed. Medicala, 1997. 44.TUDOSE C, MANIU M., MANIU C.L. – Genetică umană, Ed. Corson., Iaşi, 2000.
45.TUDOSE C., PATRAŞ XENIA - Farmacogenetica – rolul unei discipline de graniţă în medicină, Juventostomatologia, Supliment al Revistei de Medicină Stomatologică, Vol. I, Ed. Apollonia, 2003.
46.TAYLOR D.R., DRAZEN J.M., HERBISON G.P. – Asthma exacerbations during long term beta agonist use: inluence of beta 2 adrenoreceptor polymorphism, Thorax, 55:762-767, 2000.
47.VOICU A.V., MIRCIOIU C. – Mecanisme farmacologice la interferente membranare, Ed. Academiei, Bucuresti, 1996.
48.WOLF C.R., SMITH G., SMITH R.L. – Pharmacogenetics, BMJ, 320: 987-990, 2000.
49.*** Agenda Medicală, 1996, 2000, 2001
50.*** British National Formulary, 2000.
51.*** Dictionaire Vidal, Ed. Du Vidal, 1995.
52.*** Farmacopeea Română Ed. a X-a.
53.*** MP100 System Guide – Reference Manual, BIOPAC Systems Inc., Santa Barbara, USA, 2001.